This is a heavily interactive web application, and JavaScript is required. Simple HTML interfaces are possible, but that is not what this is.
Post
Newsramp
newsramp.com
did:plc:xlsujlrwr5xpfxgaf4pixhri
Lantern Pharma cuts R&D spending 47% YoY while advancing oncology trials and launching withZeta.ai, its commercial AI drug development platform. New financing extends runway to Q1 2027. #Oncology #AI
2026-05-21T00:39:30.272Z